NCT03882580 Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care
| NCT ID | NCT03882580 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Groupe Hospitalier Pitie-Salpetriere |
| Condition | Cardiovascular Complication |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2019-03-01 |
| Primary Completion | 2030-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2019-03-01 with a primary completion date of 2030-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Several Drugs used in routine care in oncology induce rare but often severe or fatal cardiovascular or metabolic side effects. This study will investigate, evaluate, report and treat the cardiovascular side effects of anticancer drugs, through a specific cardiovascular routine checkup and follow-up taking place in several Cardio-oncology programs throughout France. The different including centers will be: Assistance Publique - Hôpitaux de Paris (APHP.6: Pitié-Salpétrière, Saint Antoine and Tenon's hospitals, Paris, France).
Eligibility Criteria
Inclusion Criteria: * Suffering a cancer * Evaluated within a cardio-oncology program Exclusion Criteria: * None
Contact & Investigator
Frequently Asked Questions
Who can join the NCT03882580 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiovascular Complication. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03882580 currently recruiting?
Yes, NCT03882580 is actively recruiting participants. Contact the research team at joe-elie.salem@aphp.fr for enrollment information.
Where is the NCT03882580 trial being conducted?
This trial is being conducted at Paris, France, Paris, France, Paris, France.
Who is sponsoring the NCT03882580 clinical trial?
NCT03882580 is sponsored by Groupe Hospitalier Pitie-Salpetriere. The trial plans to enroll 5,000 participants.